Genmab A/S ADR (GMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | GMAB | BMY | AMGN | GILD | REGN |
Company | Genmab A/S ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 28.78 | 48.44 | 267.54 | 67.35 | 903.88 |
High | 28.84 | 48.55 | 268.77 | 67.55 | 911.64 |
Low | 28.44 | 47.70 | 263.39 | 66.89 | 899.90 |
Last | 28.53 | 47.84 | 264.07 | 66.93 | 901.19 |
Change | -0.90 | -0.42 | -1.57 | -0.38 | +7.05 |
% Change | -3.06% | -0.87% | -0.59% | -0.56% | +0.79% |
Volume | 358,638 | 11,758,094 | 2,174,773 | 5,286,987 | 468,666 |
20-Day Average Volume | 385,822 | 11,395,250 | 2,225,979 | 6,258,329 | 440,503 |
Previous Close | 29.43 | 48.26 | 265.64 | 67.31 | 894.14 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 29.77 | 51.17 | 273.48 | 70.61 | 942.39 |
20-Day Raw Stochastic | 3.48% | 2.07% | 2.70% | 0.54% | 12.11% |
20-Day Relative Strength | 42.58% | 34.65% | 37.63% | 29.70% | 35.14% |
Weighted Alpha | -29.79 | -31.08 | +4.99 | -24.05 | +13.20 |
Today's Opinion | 80% Sell | 56% Sell | 56% Sell | 100% Sell | 24% Buy |
Previous Opinion | 56% Sell | 56% Sell | 40% Sell | 100% Sell | 24% Buy |
Last Month's Opinion | 40% Sell | 24% Sell | 8% Sell | 88% Sell | 80% Buy |
Performance | |||||
5-Days | |||||
%Chg | -4.74% since 04/10/24 | -4.87% since 04/10/24 | -0.89% since 04/10/24 | -1.75% since 04/10/24 | -3.74% since 04/10/24 |
Low | 28.44 on 04/17/24 | 47.70 on 04/17/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 890.43 on 04/16/24 |
High | 30.11 on 04/11/24 | 50.58 on 04/11/24 | 273.00 on 04/11/24 | 69.03 on 04/11/24 | 930.64 on 04/11/24 |
1-Month | |||||
%Chg | -4.71% since 03/15/24 | -8.60% since 03/15/24 | -1.79% since 03/15/24 | -9.17% since 03/15/24 | -6.56% since 03/15/24 |
Low | 28.44 on 04/17/24 | 47.70 on 04/17/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 890.43 on 04/16/24 |
High | 31.02 on 03/26/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
3-Month | |||||
%Chg | -2.13% since 01/17/24 | -4.28% since 01/17/24 | -13.16% since 01/17/24 | -22.61% since 01/17/24 | -3.01% since 01/17/24 |
Low | 26.32 on 02/13/24 | 47.58 on 02/06/24 | 263.39 on 04/17/24 | 66.89 on 04/17/24 | 890.43 on 04/16/24 |
High | 31.88 on 03/13/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
6-Month | |||||
%Chg | -10.62% since 10/17/23 | -16.61% since 10/17/23 | -7.15% since 10/17/23 | -16.84% since 10/17/23 | +7.69% since 10/17/23 |
Low | 26.32 on 02/13/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 66.89 on 04/17/24 | 769.19 on 10/27/23 |
High | 32.89 on 11/17/23 | 57.59 on 10/18/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
Key Statistics | |||||
Market Capitalization, $K | 19,459,998 | 97,811,392 | 142,361,536 | 83,806,128 | 98,142,600 |
Shares Outstanding, K | 661,230 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
Annual Sales | 2,392,030,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
Annual Net Income | 631,910,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
Last Quarter Sales | 674,810,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
Last Quarter Net Income | 90,250,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
60-Month Beta | 0.99 | 0.39 | 0.58 | 0.19 | 0.11 |
Per-Share Information | |||||
Most Recent Earnings | 0.36 on 02/14/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
Latest Earnings Date | 05/08/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 25.01 | 6.47 | 14.24 | 10.08 | 23.91 |